Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -13.54% is 66% above its 5-year average of -39.40%, near the high end of its 5-year range (-156.93%–23.30%).
23.14% below its 12-month average of -11.00%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -18.13%.
NET PROFIT MARGIN
-13.54%
NET PROFIT MARGIN AVG TTM
-11.00%
NET PROFIT MARGIN AVG 3Y
-21.15%
NET PROFIT MARGIN AVG 5Y
-39.40%
NET PROFIT MARGIN AVG 10Y
-64.90%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-23.14%
CURRENT VS 3Y AVG
+35.97%
CURRENT VS 5Y AVG
+65.63%
CURRENT VS 10Y AVG
+79.14%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 736 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Akebia Therapeutics, Inc.
Market Cap
$239.69M
Net Profit Margin
-13.54%
TTM Avg
-11.00%
3Y Avg
-21.15%
5Y Avg
-39.40%
Market Cap
$240.04M
Net Profit Margin
-2543.74%
TTM Avg
-5120.97%
3Y Avg
-6084.02%
5Y Avg
-4060.63%
Market Cap
$239.19M
Net Profit Margin
-155582.08%
TTM Avg
-91683.52%
3Y Avg
-62749.43%
5Y Avg
-41832.95%
Market Cap
$243.34M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$243.66M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$236.81M
Net Profit Margin
-4.52%
TTM Avg
-4.68%
3Y Avg
-9.38%
5Y Avg
-10.81%
Market Cap
$243.71M
Net Profit Margin
N/A
TTM Avg
-26.91%
3Y Avg
-35.21%
5Y Avg
-46.29%
Market Cap
$235.18M
Net Profit Margin
-8.70%
TTM Avg
-47.52%
3Y Avg
-47.68%
5Y Avg
-98.44%
Market Cap
$244.52M
Net Profit Margin
-183.90%
TTM Avg
-383.83%
3Y Avg
-191.92%
5Y Avg
-127.94%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Akebia Therapeutics, Inc. (AKBA) | $239.69M | -13.54% | -11.00% | -21.15% | -39.40% |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $240.04M | -2543.74% | -5120.97% | -6084.02% | -4060.63% |
| InflaRx N.V. (IFRX)vs › | $239.19M | -155582.08% | -91683.52% | -62749.43% | -41832.95% |
| Galectin Therapeutics Inc. (GALT)vs › | $243.34M | 0.00% | 0.00% | 0.00% | 0.00% |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $243.66M | 0.00% | 0.00% | 0.00% | 0.00% |
| High Tide Inc. (HITI)vs › | $236.81M | -4.52% | -4.68% | -9.38% | -10.81% |
| Lifecore Biomedical, Inc. (LFCR)vs › | $243.71M | N/A | -26.91% | -35.21% | -46.29% |
| MacroGenics, Inc. (MGNX)vs › | $235.18M | -8.70% | -47.52% | -47.68% | -98.44% |
| Invivyd, Inc. (IVVD)vs › | $244.52M | -183.90% | -383.83% | -191.92% | -127.94% |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $245.13M | -29747.89% | 0.00% | 0.00% | 0.00% |
Operating Margin
9.9%
Net Profit Margin
-13.5%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -18.13% |
| 2026-03-31 | -16.91% |
| 2025-12-31 | -21.25% |
| 2025-09-30 | 0.92% |
| 2025-06-30 | 0.40% |
| 2025-03-31 | 10.66% |
| 2024-12-31 | -49.04% |
| 2024-09-30 | -53.54% |
| 2024-06-30 | -19.66% |
| 2024-03-31 | -55.16% |
| 2023-12-31 | 1.09% |
| 2023-09-30 | -34.46% |
| 2023-06-30 | -19.82% |
| 2023-03-31 | -67.18% |
| 2022-12-31 | -13.69% |
| 2022-09-30 | -111.05% |
| 2022-06-30 | 23.30% |
| 2022-03-31 | -101.17% |
| 2021-12-31 | -121.13% |
| 2021-09-30 | -122.13% |
| 2021-06-30 | -156.93% |
| 2021-03-31 | -133.03% |
| 2020-12-31 | -153.44% |
| 2020-09-30 | -99.95% |
| 2020-06-30 | -194.97% |
| 2020-03-31 | -68.66% |
| 2019-12-31 | -135.84% |
| 2019-09-30 | -59.35% |
| 2019-06-30 | -57.71% |
| 2019-03-31 | -99.66% |
| 2018-12-31 | -147.65% |
| 2018-09-30 | -48.99% |
| 2018-06-30 | -69.82% |
| 2018-03-31 | -50.99% |
| 2017-12-31 | 14.06% |
| 2017-09-30 | -56.04% |
| 2017-06-30 | -75.45% |
| 2017-03-31 | -213.48% |
| 2016-12-31 | -2466.58% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
